Quantifying drug release from PLGA nanoparticulates

European Journal of Pharmaceutical Sciences

Volumn 37, Issue 3-4, 2009, Pages 477-485

  Corrigan, Owen I ^a   Li, Xue ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bulk degradation; Drug release; Nanoparticles; PLGA

Indexed keywords

COUMARIN 6; COUMARIN DERIVATIVE; HUMAN SERUM ALBUMIN; INDOMETACIN; KETOPROFEN; OVALBUMIN; PHOSPHATE BUFFERED SALINE; PLGA; POLYGLACTIN; SOLVENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DIFFUSION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; EVAPORATION; NANOENCAPSULATION; NANOFABRICATION; PH; PRIORITY JOURNAL;

ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DELAYED-ACTION PREPARATIONS; DIFFUSION; EXCIPIENTS; INDOMETHACIN; KETOPROFEN; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MODELS, STATISTICAL; MOLECULAR WEIGHT; NANOPARTICLES; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; POLYGLYCOLIC ACID; SERUM ALBUMIN; SOLUBILITY;

EID: 66049113578     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.04.004     Document Type: Article

References (63)

1. Alexis F. Factors affecting the degradation and drug release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polymer International 54 (2005) 36-46
2. Arifin D.Y., Lee L.Y., and Wanh C.-H. Mathematical modelling and simulation of drug release from microspheres: Implications to drug delivery systems. Advanced Drug Delivery Reviews 58 (2006) 1274-1325
3. Astete C.E., and Sabliov C.M. Synthesis and charaterization of PLGA nanoparticles. Journal of Biomaterials Science, Polymer Edition 17 (2006) 247-289
4. Barichell J.M., Morishita M., Takayama K., and Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Development and Industrial Pharmacy 25 4 (1999) 471-476
5. Batycky R.P., Hanes J., Langer R., and Edwards D.A. A Theoretical model of erosion and macromolecular drug release from biodegrading microspheres. Journal of Pharmaceutical Sciences 86 (1997) 1464-1477
6. Beck L.R., Cowsar D.R., Lewis D.H., Cosgrove R.J., Riddle C.T., Lowry S.L., and Epperly T. A new long-acting injectable microcapsule system for the administration of progesterone. Fertility and Sterility 31 (1979) 545-551
7. Benita S., Benoit J.P., Puisieux F., and Thies C. Characterisation of drug loaded poly(d,l-lactide) microspheres. Journal of Pharmaceutical Sciences 73 (1984) 1721-1724
8. Blanco M.D., and Alonso M.J. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. European Journal of Pharmaceutics & Biopharmaceutics 43 1997 (1997) 287-294
9. Blasi P., Schoubben A., Giovagnoli S., Perioli L., Ricci M., and Rossi C. Ketoprofen poly(lactide-co-glycolide) physical interactions. AAPSPharmSciTech 8 2 (2007). http://www.aapspharmscitech.org/ (article 37, www.aapspharmscitech.org)
10. Bonny J.D., and Leuenberger H. Matrix type controlled release systems: 1. Effect of percolation on drug dissolution kinetics. Pharmaceutica Acta Helvetiae 66 (1991) 160-164
11. Chiou W.L., and Kyle L.E. Differential thermal, solubility, and aging studies on various sources of digoxin and digitoxin powder: biopharmaceutical implications. Journal of Pharmaceutical Sciences 68 (1979) 1224-1229
12. Conti B., Pavanetto F., and Genta I. Use of polylactic acid for the preparation of microparticulate drug delivery systems. Journal of Microencapsulation 9 (1992) 153-166
13. Coombes A.G., Yeh M.-K., Lavelle E.C., and Davis S.S. The control of protein release from PLGA microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. Journal of Controlled Release 52 (1998) 311-320
14. Corrigan O.I., and Heelan B.A. Characterization of drug release from diltiazem-loaded polylactide microspheres prepared using sodium caseinate and whey protein as emulsifying agents. J. Microencapsulation 18 (2001) 335-345
15. Dunne M., Corrigan O.I., and Ramtoola Z. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials 21 (2000) 1659-1668
16. Dunne, M., Ramtoola, Z., Corrigan, O.I., 2009. Fluphenazine release from biodegradable microparticles: characterization and modelling of release. Journal of Microencapsulation, doi:10.1080/02652040802396575.
17. Ehtezazi T., Washington C., and Melia C.D. First order release from porous PLA microspheres with limited exit holes on the exterior surface. Journal of Controlled Release 66 (2000) 27-38
18. Eley J.G., Pujari D.V., and McLane J. Poly (lactide-co-glycolide) nanoparticles containing coumarin-6 for suppository delivery: in vitro release profile and in vivo tissue distribution. Drug Delivery 11 4 (2004) 255-261
19. Faisant N., Siepmann J., and Benoit J.P. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. European Journal of Pharmaceutical Sciences 15 (2002) 355-366
20. Fitzgerald, J.F., Corrigan, O.I., 1993. Mechanisms governing drug release from poly-hydroxy aliphatic esters. Diltiazem base release from poly(lactide-co-glycolide) delivery systems. In: El-Nokaly, M.A., Piatt, D.M., Charpentier, B.A. (Eds.), Polymeric Delivery Systems, Properties and Applications, ACS Symposium Series 520. American Chemical Society, Washington, DC, pp. 311-326.
21. Fitzgerald J.F., and Corrigan O.I. Investigation of the mechanisms governing the release of levamisole from poly-lactide-co-glycolide delivery systems. Journal of Controlled Release 42 (1996) 125-132
22. Florence A.T. The oral absorption of micro and nanoparticles: neither exceptional nor unusual. Pharmaceutical Research 14 (1997) 259-266
23. Gallagher K.M., and Corrigan O.I. Mechanistic aspects of the release of levamisole hydrochloride from biodegradable polymers. Journal of Controlled Release 69 (2000) 261-272
24. Gabor F., Ertl B., Wirth M., and Mallinger R. Ketoprofen-poly(d,l-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. Journal of Microencapsulation 16 1 (1999) 1-12
25. Gutierro I., Hernández R.M., Igartua M., Gascón A.R., and Pedraz J.L. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanoparticles. Vaccine 21 (2002) 67-77
26. Guiziou B., Armstrong D.J., Elliot P.N.C., Ford J.L., and Rostron C. Investigation of in-vitro release characteristics of NSAID-loaded polylactic acid microspheres. Journal of Microencapsulation 13 (1996) 701-708
27. He J., Zhong C., and Mi J. Modeling of drug release from bioerodible polymer matrices. Drug Delivery 12 (2005) 251-259
28. Huffman K., and Casey D. Effect of carboxyl end groups on hydrolysis of polyglycolic acid. Journal of Polymer Science: Polymer Chemistry Edition 23 (1985) 1939-1951
29. Jalil R., and Nixon R.J. Effect of temperature of dissolution on the release kinetics of phenobarbitone from poly (d,l-lactic acid) microcapsules: calculation of activation energy. Drug Development and Industrial Pharmacy. 16 (1990) 2257-2266
30. Jacobs P.W.M. Formation and growth of nuclei and the growth of interfaces in the chemical decomposition of solids, new insights. Journal of Physical Chemistry B 101 (1997) 10086-10093
31. Jung J.H., Ree M., and Kim H. Acid- and base-catalysed hydrolyses of aliphatic polycarbonates and polyesters. Catalysis Today 115 (2006) 283-287
32. Khin Y.W., and Feng S.S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26 (2005) 2713-2722
33. Köping-Höggård M., Sánchez A., and Alonso M.J. Nanoparticles as carriers for nasal vaccine delivery. Expert Review of Vaccines 4 (2005) 185
34. Lalla J.K., and Sapna K. Biodegradable microspheres of poly (dl-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route. Journal of Microencapsulations 10 (1993) 449-460
35. Leelarasamee N., Howard S.A., Malanga C.J., Luzzi L.A., Hogan T.F., Kandzari S.J., and Ma J.K.H. Kinetics of drug release from polylactic acid-hydrocortisone microcapsules. Journal of Microencapsulation 3 (1986) 171-179
36. Li L., and Schwendeman S. Mapping neutral microclimate pH in PLGA microspheres. Journal of Controlled Release 101 (2005) 163-173
37. Lund W. The Pharmaceutical Codex. 12th Ed. (1994), The Pharmaceutical Press, London, UK
38. Milallos R.G., Alexander K., and Riga A. Investigation of the interaction between acidic, basic, neutral and zwitterionic drugs with poly-l-lactic acid by thermal and analytical methods. Journal of Thermal Analysis and Calorimetry 93 (2008) 289-294
39. Mollo A.R., and Corrigan O.I. An investigation of the mechanism of release of the amphoteric drug amoxycillin from poly(dl-lactide-co-glycolide) matrices. Pharmaceutical Development and Technology 7 (2002) 333-343
40. Mollo A.R., and Corrigan O.I. Effect of poly hydroxy aliphatic ester polymer type on amoxycillin release from cylindrical compacts. International Journal of Pharmaceutics 268 (2003) 71-79
41. Niwa T., Takeuchi H., Hino T., Kunou N., and Kawashima Y. Preparation of biodegradable nanospheres of water-soluble and insoluble drugs with d,l-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method and the drug release behaviour. Journal of Controlled Release 25 (1992) 89-98
42. Panyam J., Dali M.M., Sahoo S.K., Ma W., Chakravarthi S.S., Amidon G.L., Levy R.J., and Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles. Journal of Controlled Release 92 (2003) 173-187
43. Pietzonka P., Rothen-Rutishauser B., Langguth P., Wunderli-Allenspach H., Walter E., and Merkle H.P. Transfer of lipophilic markers from PLGA and polystyrene nanoparticles to Caco-2 monolayers mimics particle uptake. Pharmaceutical Research 19 5 (2002) 595-601
44. Pradhan R.S., and Vasavada R.C. Formulation and in vitro release study on poly (d,l-lactide) microspheres containing hydrophilic compounds: glycine homopeptides. Journal of Controlled Release 30 (1994) 143-154
45. Prout E.G., and Tompkins F.C. The thermal decomposition of potassium permanganate. Transactions of the Faraday Society 40 (1944) 488-498
46. Puebla P., Pastoriza P., Barcia E., and Fernandez-Carballido A. PEG-derivative effectively modifies the characteristics of indomethacin-PLGA microspheres destined to intra-articular administration. Journal of Microencapsulation 22 7 (2005) 793-808
47. Qaddoumi M.G., Ueda H., Yang J., and Davda J. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjuctival epithelial cell layers. Pharmaceutical Research 21 (2004) 641-648
48. Ramtoola Z., Corrigan O.I., and Barrett C.J. Release kinetics of fluphenazine from biodegradable microspheres. Journal of Microencapsulation 9 (1992) 415-423
49. Rothstein S.N., Federspiel W.J., and Little S.R. A simple model framework for the prediction of controlled release from bulk eroding polymer matrices. Journal of Materials Chemistry 18 (2008) 1873-1880
50. Sah H., Toddywala R., and Chien Y.W. The influence of biodegradable formulations on the controlled release of a protein. Journal of Controlled Release 30 (1994) 201-211
51. Sanders L.M., Kent J.S., Mc Rae G.I., Vickery B.H., Tice T.R., and Lewis D.H. Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres. Journal of Pharmaceutical Science 73 (1984) 1294-1297
52. Shah S.S., Cha Y., and Pitt C.G. Poly(glycolic acid-co-d,l-lactic acid): diffusion or degradation controlled drug delivery. Journal of Controlled Release 18 (1992) 261-270
53. Siegel S.J., Kahn J.B., Metzger K., Winey K.I., Werner K., and Dan N. Effect of drug type on the degradation rate of PLGA matrices. European Journal of Pharmaceutics and Biopharmaceutics 64 (2006) 287-293
54. Siepmann J., and Goepferich A. Mathematical modelling of bioerodible, polymeric drug delivery systems. Advanced Drug Delivery Reviews 48 (2001) 229-247
55. Siepmann J., Elkharraz K., Siepmann F., and Klose D. How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment. Biomacromolecules 6 4 (2005) 2312-2319
56. Somasundaran P. Encyclopaedia of Surface and Colloid Science (2006), CRC Press 711
57. Souillac P., and Rytting J.H. Characterization of delivery systems, Differential Scanning Calorimetry. Encyclopedia of Controlled Drug Delivery 1 (1999) 212-227
58. Spenlehauer G., Vert M., Benoit J.P., Chabot F., and Veillard M. Biodegradable cisplatin microspheres prepared by the solvent evaporation method: morphology and release characteristics. Journal of Controlled Release 7 (1988) 217-229
59. Vert M., Li S., and Garreau H. More about the degradation of LA/GA-derived matrices in aqueous media. Journal of Controlled Release 16 (1991) 15-26
60. Wakiyama N., Juni K., and Nakano M. Preparation and evaluation in vitro of polylactic acid microspheres containing local anaesthetics. Chemical and Pharmaceutical Bulletin 29 (1981) 3363-3368
61. Yang Y.Y., and Chung T.S. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 22 (2001) 231-241
62. Wagner J.G. Pharmacokinetics for the Pharmaceutical Scientist (1993), Technomic Publishing, Lancaster, PA pp. 83-85
63. Zigoneanu I.G., Astete C.E., and Mirela-Sabliov C. Nanoparticles with entrapped α-tocopherol: synthesis, characterization, and controlled release. Nanotechnology 19 10 (2008) 105606-105606.8